INNT
TOTAL INVALIDATION PROCESSED BY THE IB
10/12/2024
Back to search
Official data from USPTO
INSPIRED IPSEN'S NEUROTOXINS PLATFORM IN RESEARCH EXPERTISE AND DEVELOPMENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
10/12/2024
Trademark type
Combined
Nice classes
41, 42, 44
Filing date
05/26/2016
Registration date
07/04/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/19/2024
Last transaction
01/19/2024
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
24
Owner location
WREXHAM, GB
Examiner
ROBERTSON, DEIRDRE
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of an outline of a person's head in blue with a design of a brain in darker blue inside the outline, the word "INSPIRED" in blue with gray rays above, and the wording "Ipsen's NeurotoxinS Platform In Research Expertise and Development" primarily in grey with the first letters of each term and the "S" in "NeurotoxinS" in blue. The color white is not claimed as a feature of the mark and represents background and transparent areas.
Holders and representatives
Holders
IPSEN BIOPHARM LIMITED
Representatives
G MATHEW LOMBARD LOMBARD & GELIEBTER LLP
Technical classification
Nice Classes
Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Educationproviding of training in the fields of medicinemedical researchpharmaceutical productsneurology and neurotoxins; Arranging and conducting of educational conferencescongresses and symposiums in the fields of medicinemedical researchpharmaceutical productsneurology and neurotoxins
Class 42
Scientific and industrial research in the fields of medicinemedical researchpharmaceutical productsneurology and neurotoxins; Medical research services; Pharmaceutical research and development; Research relating to biotechnology
Class 44
Medical services; providing medical information
Publications
History of USPTO decisions and trademark events.
30 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/24/2024
INPC
INVALIDATION PROCESSED
09/24/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
09/20/2024
C71T
CANCELLED SECTION 71
01/19/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/04/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/04/2017
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
10/05/2017
XXCR
GENERIC MADRID TRANSACTION CREATED
10/05/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/04/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
07/04/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/18/2017
PUBO
PUBLISHED FOR OPPOSITION
04/18/2017
GPNX
NOTIFICATION PROCESSED BY IB
04/15/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/29/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/29/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/29/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/09/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/08/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/08/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/08/2017
RFNT
REFUSAL PROCESSED BY IB
10/16/2016
MAFR
APPLICATION FILING RECEIPT MAILED
09/27/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/26/2016
RFRR
REFUSAL PROCESSED BY MPU
09/26/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/25/2016
CNRT
NON-FINAL ACTION WRITTEN
09/24/2016
DOCK
ASSIGNED TO EXAMINER
09/23/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/23/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/22/2016
Continuous trademark protection
Get notified about every new filing that threatens INSPIRED IPSEN'S NEUROTOXINS PLATFORM IN RESEARCH EXPERTISE AND DEVELOPMENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.